Orion Capital Management’s Quest Diagnostics DGX Stock Holding History

Orion Capital Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$14.8K	Hold	70	–	–	﹤0.01%	380
2026 Q1	$13.7K	Hold	70	–	–	﹤0.01%	348
2025 Q4	$12.1K	Hold	70	–	–	﹤0.01%	376
2025 Q3	$13.3K	Hold	70	–	–	﹤0.01%	370
2025 Q2	$12.6K	Hold	70	–	–	﹤0.01%	350
2025 Q1	$11.8K	Hold	70	–	–	0.01%	347
2024 Q4	$10.6K	Buy	+70	New	+$10.9K	﹤0.01%	355
2024 Q3	–	Sell	-70	Closed	-$9.58K	–	236
2024 Q2	$9.58K	Hold	70	–	–	0.01%	354
2024 Q1	$9.32K	Hold	70	–	–	﹤0.01%	381
2023 Q4	$9.65K	Hold	70	–	–	0.01%	383
2023 Q3	$8.53K	Buy	+70	New	+$9.33K	0.01%	389
2023 Q2	–	Sell	-70	Closed	-$9.9K	–	227
2023 Q1	$9.9K	Buy	+70	New	+$10K	0.01%	375

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Orion Capital Management's DGX Position: Q2 2026 in Review

Orion Capital Management held its Quest Diagnostics (DGX) position steady in Q2 2026 at 70 shares worth $14.8K. The position accounts for ﹤0.01% of the portfolio, ranked #380.

Orion Capital Management first reported a position in DGX in Q1 2023 and has held it in 12 quarters since. 1,099 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

Orion Capital Management held 70 shares of Quest Diagnostics worth $14.8K as of Q2 2026.
Orion Capital Management left its Quest Diagnostics share count unchanged in Q2 2026.
Quest Diagnostics made up ﹤0.01% of Orion Capital Management's portfolio in Q2 2026, its #380 holding.
Orion Capital Management first reported a position in Quest Diagnostics in Q1 2023 and has held it in 12 quarters since.
1,099 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Orion Capital Management's 13F filing for Q2 2026, filed 18 Aug 2026.